Panel to tackle global data disclosure challenge

Developing a new drug for a global market presents every biopharma company with a complex regulatory challenge. How can you juggle the demands of regulators in Europe and the U.S., as well as other key markets around the globe?

Join us for a unique webinar that will provide expert perspectives on maintaining fruitful relationships with a variety of regulatory agencies, with a special focus on the crucial regulatory communications required on the disclosure of clinical trial data.

We'll cover salient data disclosure requirements from around the world.

Christine Dingivan, M.D., Executive Vice President and Chief Medical Officer, PPD and Patricia Teden, Principal, Teden Consulting will be on hand to provide expert advice on managing global data disclosure challenges. The webinar will take place Thursday, June 24 at 2pm EST.

Click here to register. - George Miller

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.